Accounting Manager
Quick Summary
Financial close and reporting processes Drive the monthly, quarterly, and annual financial close processes in accordance with US GAAP, including managing the accounting for accruals,
Bachelor’s degree in Accounting, CPA preferred. 5+ years of progressive accounting experience, including at least 2 years in a manager or supervisory role. Prior experience in biotechnology,
Nice to Have
~1 min readReporting to the Senior Manager, Accounting, the Accounting Manager will manage Celcuity’s close process to ensure the accuracy, transparency, and regulatory compliance of Celcuity’s financial statements. The ideal candidate will have extensive experience with driving the close process, equity administration, operational initiatives and supporting SOX 404(b) readiness.
Responsibilities
~1 min read- Drive the monthly, quarterly, and annual financial close processes in accordance with US GAAP, including managing the accounting for accruals, accounts receivable, and sales commission calculations.
- Support Celcuity’s employee stock purchase plan, including contributions, purchases, preparation of individual employee statements, and related journal entries.
- Support operational initiatives, such as coordinating insurance policy renewals, managing VAT return filings, and other ad hoc projects as needed.
- Assist with the design, implementation, and maintenance of robust internal control procedures, including supporting Celcuity's SOX 404(b) readiness initiatives.
- Oversee the accounts payable function, including invoice processing, vendor management, reconciliations, and timely disbursements in alignment with company policies.
- Serve as a key point of contact for external auditors, facilitating efficient quarterly reviews and annual audits.
- Mentor and develop staff within the accounting and accounts payable functions, fostering a collaborative environment focused on professional growth.
- Collaborate closely with the Senior Manager, Accounting and Assistant Controller on strategic initiatives and cross-functional projects.
Requirements
~1 min read- Bachelor’s degree in Accounting, CPA preferred.
- 5+ years of progressive accounting experience, including at least 2 years in a manager or supervisory role.
- Prior experience in biotechnology, pharmaceuticals, or life sciences strongly preferred.
- Hands-on experience managing the monthly and quarterly financial close process and executing internal controls in a SOX-compliant environment; experience supporting SOX 404(b) implementation or readiness projects a plus.
- Proven expertise with stock-based compensation accounting, equity award activity, and annual tax reporting.
- Experience supporting various operational and administrative functions across the organization.
- Prior experience in accounting for accruals and R&D expenses, with a track record of effective cross-functional collaboration.
- Continuous improvement mindset; seeking ways to drive innovation and efficiencies.
- Outstanding organizational skills, attention to detail and ability to manage multiple processes and documentation requirements.
- Excellent written and verbal communication skills, with ability to influence and build credibility at all levels.
- Strong analytical skills with advanced proficiency in MS Office including Word, Excel, and PowerPoint.
Celcuity is a clinical-stage, publicly traded biotechnology company seeking to extend the lives of cancer patients through the development of targeted therapies for the treatment of multiple solid tumor indications. The company was founded to develop a better way to treat the cellular drivers of tumor growth.
Our lead therapeutic candidate, gedatolisib, is an intravenously administered, potential first-in-class PI3K/AKT/mTOR (PAM) pathway inhibitor. Its mechanism of action and pharmacokinetic properties are highly differentiated from other currently approved and investigational therapies that target PI3K or mTOR alone or together. Gedatolisib phase 3 clinical development programs are focused on the treatment of patients with HR+/HER2- ABC in the 1L and 2L settings. A Phase 1b/2 clinical trial evaluating gedatolisib in combination with darolutamide in patients with metastatic castration resistant prostate cancer, is on-going.
Celcuity is committed to fair and equitable compensation practices, and we strive to provide employees with total compensation packages that are competitive. For this role, the anticipated base pay range is $120,000-$140,000 DOE. The exact base pay offered for this role will depend on various factors, including but not limited to the candidate’s geography, qualifications, skills, and experience.
The successful candidate will be eligible for an annual performance incentive bonus and a new hire equity package. Celcuity also offers various benefits offerings, including, but not limited to, medical, dental, vision insurance, 401(k) match, PTO, and paid holidays.
Recruiters and staffing agencies should not contact Celcuity through this page. All recruitment vendors (search firms, recruitment agencies, and staffing companies) are prohibited from contacting our hiring manager(s), executive team members, or employees directly.
We require that all recruiters and staffing agencies have a fully executed, formal written agreement on file. Celcuity’s receipt or acceptance of an unsolicited resume submitted by a vendor organization to this website or employee does not constitute an actual or implied contract between Celcuity and such organization and will be considered unsolicited. Celcuity will not be responsible for related fees.
Location & Eligibility
Listing Details
- Posted
- June 18, 2026
- First seen
- June 18, 2026
- Last seen
- June 18, 2026
Posting Health
- Days active
- 0
- Repost count
- 0
- Trust Level
- 67%
- Scored at
- June 18, 2026
Signal breakdown
Please let Celcuity know you found this job on Jobera.
3 other jobs at Celcuity
View all →Explore open roles at Celcuity.
Similar Accounting Manager jobs
View all →Browse Similar Jobs
Stay ahead of the market
Get the latest job openings, salary trends, and hiring insights delivered to your inbox every week.
No spam. Unsubscribe at any time.